Search

everythinglearnresearchcommunity

for

Search:↓

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

More people were diagnosed with certain skin diseases and sexually transmitted diseases in 2014 compared to 2003 in a Brazilian public institution.

Retinoids are effective for skin conditions like severe acne and psoriasis but must be used with caution due to potential side effects and risks during pregnancy.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

People with more than 11 skin tags, especially on the thigh, neck, or armpit, may have a higher chance of metabolic syndrome.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

A new treatment using a special gel with miR-665 reduces inflammation and helps hair regrow in alopecia areata.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Spironolactone is safe for treating hair loss in women without causing low blood pressure.

The term "low-risk" in myelodysplastic syndrome is misleading and should be changed to better reflect patient experiences and needs.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Low-dose finasteride may increase erectile dysfunction risk over time.

Finasteride is considered to have a low risk to fetuses.

Spironolactone helps prevent swelling caused by minoxidil in women with hair loss.

Low iron levels are linked to more hair loss in non-menopausal women.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

Low platelet count and hematocrit may increase the risk of hair loss in dengue fever patients.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Low quality of life and high HSS-29 scores increase risk of losing patients during treatment.

Selenium levels are similar in healthy people from both high and low NPC risk areas.

Early hair greying may increase the risk of heart disease.

People with vitiligo may have a lower risk of heart disease.

Low dose oral minoxidil can help with hair growth but may cause serious heart problems, so doctors need to be careful.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

Patients with mycosis fungoides have a higher risk of heart disease.

Women with PCOS have higher cardiometabolic risks.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.